Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Givaudan's Total Liabilities for the quarter that ended in Jun. 2026 was €8,344 Mil.
Givaudan's quarterly Total Liabilities
increased
from Jun. 2025 (€7,644.36 Mil) to Dec. 2025 (€7,818.78 Mil) and
increased
from Dec. 2025 (€7,818.78 Mil) to Jun. 2026 (€8,344.44 Mil).
Givaudan's annual Total Liabilities
increased
from Dec. 2023 (€7,560.37 Mil) to Dec. 2024 (€8,055.80 Mil) but then
declined
from Dec. 2024 (€8,055.80 Mil) to Dec. 2025 (€7,818.78 Mil).
Givaudan Total Liabilities Related Terms
Givaudan Total Liabilities Historical Data
* Premium members only.
The historical data trend for Givaudan's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Givaudan's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Givaudan (STU:GIN1) has a Total Liabilities of €8,344 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Givaudan and its competitors.
Is Givaudan's Total Liabilities too high?
Givaudan's current Total Liabilities is €8,344 Mil. Overall, Givaudan has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Givaudan's Total Liabilities compare to LIN and SHW?
Givaudan's Total Liabilities of €8,344 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Chemicals company?
A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Givaudan and its competitors. Givaudan's current Total Liabilities is €8,344 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Givaudan stock overvalued right now?
Based on GuruFocus' analysis, Givaudan (STU:GIN1) is currently considered Modestly Undervalued. The stock's GF Value™ is €79.84, compared to a current price of €68.50 — trading 14.2% below its estimated fair value. The current Total Liabilities is €8,344 Mil. Givaudan's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Givaudan (STU:GIN1), the current Total Liabilities is €8,344 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Givaudan (STU:GIN1) Overvalued in 2026?
Based on GuruFocus' analysis, Givaudan stock appears to be undervalued.
The current stock price of €68.50 is trading 14.2% below its estimated GF Value™ of €79.84.
GuruFocus considers Givaudan to be Modestly Undervalued.
Key valuation signals for STU:GIN1:
Total Liabilities: €8,344 Mil
GF Value™: €79.84 vs. price of €68.50 (14.2% below fair value)
No single metric tells the full story. See the STU:GIN1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spun off from Roche in 2000, Givaudan is one of the world's leading flavor and fragrance manufacturers, with a presence in more than 80 countries. It sources more than 11,000 different ingredients from over 100 countries. The company serves end consumer markets with fragrances for personal, home, and laundry care brands, including prestige perfumes. In flavors, customers are in beverages, savory, snacks, sweet goods, and dairy. Givaudan has more than 17,000 employees, and its perfumery team is the largest in the industry.
86GF Score
Get the complete analysis for STU:GIN1
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:GIN1 has been successfully added to your 
